Products Categories
| CAS No.: | 502-85-2 |
|---|---|
| Name: | SODIUM 4-HYDROXYBUTYRATE |
| Article Data: | 18 |
| Molecular Structure: | |
|
|
|
| Formula: | C4H8 O3 . Na |
| Molecular Weight: | 126.088 |
| Synonyms: | Butanoicacid, 4-hydroxy-, monosodium salt (9CI); Butyric acid, 4-hydroxy-, monosodiumsalt (8CI); 4 HB; 4-Hydroxybutanoic acid sodium salt; 4-Hydroxybutyrate sodium;4-Hydroxybutyric acid monosodium salt; 4-Hydroxybutyric acid sodium salt; DEA2100; EB 27; Gam-OH; Gamma OH; NIH 10947; NSC 84223; Oxybate sodium; SHB;Sodium 4-hydroxybutyrate; Sodium hydroxybutyrate; Sodium oxybate; Sodium g-hydroxybutyrate; Sodium g-oxybutyrate; Somatomax PM;Somsanit; Wy 3478; Xyrem; g-Hydroxybutyrate sodium; g-Hydroxybutyric acid sodium salt; g-OH |
| Density: | g/cm3 |
| Melting Point: | 145-146 |
| Boiling Point: | 295.6°Cat760mmHg |
| Flash Point: | 146.8°C |
| Hazard Symbols: | F,T |
| Risk Codes: | 11-23/24/25-39/23/24/25 |
| Safety: | Moderately toxic by intraperitoneal route. Mildly toxic by ingestion. Experimental reproductive effects. Human systemic effects: coma, distorted perceptions, hallucinations, nausea or vomiting. When heated to decomposition it emits toxic fumes of Na2O. |
| PSA: | 57.53000 |
| LogP: | -0.15650 |
- 5156-58-1N-(1-Benzyl-4-pipperidinyl)-N-phenylpropanamide HCl
- 81281-59-67-Benzylideneaminotheophylline
- 50288-62-5threo-Phenyl-2-piperidyl acetamide
- 82993-81-5D-threo-Ritalinic acid hydrochloride
- 73441-42-6METHYL-5-CHLORO-2,2-DIMETHYLVALERATE
- 68439-39-4Poly(oxy-1,2-ethanediyl), alpha-(2-ethylhexyl)-omega-hydroxy-,
- 852475-26-4MC1568
- 958254-66-51H-Imidazo[4,5-b]pyridine-2-carboxaldehyde, 1-methyl-, hydrochloride
- 99170-93-1N-Methyl-2-oxazolamine
- 717878-06-31-(4-fluorophenyl)-4-nitro-1H-imidazole
This product is a nationally controlled contraband, and the Lookchem platform doesn't provide relevant sales information.
Chemistry
IUPAC Name: Hydroxybutyrate sodium
The MF of Hydroxybutyrate sodium (502-85-2) is C4H7NaO3.
The MW of Hydroxybutyrate sodium (502-85-2) is 126.09.
Synonyms of Hydroxybutyrate sodium (502-85-2): Hydroxybutyric acid monosodium salt ; 4-Hydroxybutanoate de sodium ; Butanoic acid, 4-hydroxy-, monosodium salt ; Natrium-4-hydroxybutanoat ; Sodium .gamma.-hydroxybutyrate
Product Categories: Aromatic Carboxylic Acids, Amides, Anilides, Anhydrides & Salts;Aliphatics;Carboxylic Acids
Form: white crystalline powder
EINECS: 207-953-3
Flash Point: 146.8 °C
Boiling Point: 295.6 °C
Melting Point: 145-146 °C
Merck: 13,4840
Uses
Hydroxybutyrate sodium (502-85-2) is general anesthetic used for neurosurgery, obstetrics and gynecology, plastic surgery, head and neck and limbs of departments of surgery and other surgical materials.
Toxicity Data With Reference
| 1. | orl-man TDLo:71 mg/kg:BAH,GIT | AJEMEN American Journal of Emergency Medicine. 9 (1991),321. | ||
| 2. | orl-rat LD50:9690 mg/kg | FATOAO Farmakologiya i Toksikologiya (Moscow). 43 (1980),714. | ||
| 3. | ipr-rat LD50:1650 mg/kg | THERAP Therapie. 32 (1977),375. | ||
| 4. | ipr-mus LD50:3330 mg/kg | JJPAAZ Japanese Journal of Pharmacology. 17 (1967),30. |
Consensus Reports
Reported in EPA TSCA Inventory.
Safety Profile
Moderately toxic by intraperitoneal route. Mildly toxic by ingestion. Experimental reproductive effects. Human systemic effects: coma, distorted perceptions, hallucinations, nausea or vomiting. When heated to decomposition it emits toxic fumes of Na2O.
Safety information of Hydroxybutyrate sodium (502-85-2):
Safety Statements
22 Do not breathe dust
24/25 Avoid contact with skin and eyes
WGK Germany 2
RTECS ET4750000
F 3